MAP2K7 and cutaneous melanoma: The Cancer Genome Atlas (TCGA) of cutaneous melanoma provides a robust picture of the molecular drivers of this disease (Table 1).6 Consistent with previous studies, the TCGA confirmed that activation of the RAS-RAF-MEK-ERK pathway is ubiquitous in this cancer.